Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
Minelab Premieres the VANQUISH 60 Series: Simple Yet Powerful
LONDON, Sept. 17, 2025 /PRNewswire/ -- Minelab officially unveiled the new VANQUISH…
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE…
Scientists Discuss the Recent CancerVax Breakthrough
The Company's scientific team describes how they successfully disguised cancer cells and…
AVITA Medical to Host Investor Webinar Briefing
August 10, 2025 19:00 ET Â | Source: AVITA Medical VALENCIA, Calif., Aug.…
Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress
PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co.,…
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer’s Association International Conference (AAIC)
Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters…
Bank of America Reports Second Quarter 2025 Financial Results
CHARLOTTE, N.C., July 16, 2025 /PRNewswire/ -- Bank of America reported its…
FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR’S AWARDEES AT CONI
ROME, June 11, 2025 /PRNewswire/ -- The sense of anticipation is increasing,…